Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pascal Lefaucheur

Showing results (281-290 of 291) with videos related to

Pageof 30
Sort By:
Pain|October 12, 2020
The Parkinson disease pain classification system: results from an international mechanism-based classification approachVeit Mylius, Santiago Perez Lloret, Rubens G Cury, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 6, 2020
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)Jean-Pascal Lefaucheur, André Aleman, Chris Baeken, et al.
Schizophrenia Bulletin|June 14, 2018
High-Frequency Neuronavigated rTMS in Auditory Verbal Hallucinations: A Pilot Double-Blind Controlled Study in Patients With SchizophreniaSonia Dollfus, Nemat Jaafari, Olivier Guillin, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 4, 2020
Corrigendum to "Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)" [Clin. Neurophysiol. 131 (2020) 474-528]Jean-Pascal Lefaucheur, André Aleman, Chris Baeken, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 19, 2014
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)Jean-Pascal Lefaucheur, Nathalie André-Obadia, Andrea Antal, et al.
Archives of Cardiovascular Diseases|August 28, 2023
Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in FranceThibaud Damy, Amira Zaroui, Marie de Tournemire, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 27, 2020
Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert GuidelinesSimone Rossi, Andrea Antal, Sven Bestmann, et al.
Lancet (London, England)|January 14, 2014
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trialStéphane Palfi, Jean Marc Gurruchaga, G Scott Ralph, et al.
The Oncologist|June 28, 2017
Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind TrialDaniel Ciampi de Andrade, Manoel Jacobsen Teixeira, Ricardo Galhardoni, et al.
Pain Reports|February 26, 2019
Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management (LAC<sub>2</sub>-NIN-CP)Abrahão Fontes Baptista, Ana Mércia B L Fernandes, Katia Nunes Sá, et al.
Pageof 30

Showing results (281-290 of 291) with videos related to

Sort By:
Pageof 30
Pain|October 12, 2020
The Parkinson disease pain classification system: results from an international mechanism-based classification approachVeit Mylius, Santiago Perez Lloret, Rubens G Cury, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 6, 2020
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)Jean-Pascal Lefaucheur, André Aleman, Chris Baeken, et al.
Schizophrenia Bulletin|June 14, 2018
High-Frequency Neuronavigated rTMS in Auditory Verbal Hallucinations: A Pilot Double-Blind Controlled Study in Patients With SchizophreniaSonia Dollfus, Nemat Jaafari, Olivier Guillin, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 4, 2020
Corrigendum to "Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)" [Clin. Neurophysiol. 131 (2020) 474-528]Jean-Pascal Lefaucheur, André Aleman, Chris Baeken, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 19, 2014
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)Jean-Pascal Lefaucheur, Nathalie André-Obadia, Andrea Antal, et al.
Archives of Cardiovascular Diseases|August 28, 2023
Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in FranceThibaud Damy, Amira Zaroui, Marie de Tournemire, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 27, 2020
Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert GuidelinesSimone Rossi, Andrea Antal, Sven Bestmann, et al.
Lancet (London, England)|January 14, 2014
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trialStéphane Palfi, Jean Marc Gurruchaga, G Scott Ralph, et al.
The Oncologist|June 28, 2017
Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind TrialDaniel Ciampi de Andrade, Manoel Jacobsen Teixeira, Ricardo Galhardoni, et al.
Pain Reports|February 26, 2019
Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management (LAC<sub>2</sub>-NIN-CP)Abrahão Fontes Baptista, Ana Mércia B L Fernandes, Katia Nunes Sá, et al.
Pageof 30